These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 4216878)

  • 1. [Whole body counting of 131I administered patients with hyperthyroidism, and estimations of absorbed doses of 131I to various organs (author's transl)].
    Saegusa K
    Nihon Igaku Hoshasen Gakkai Zasshi; 1974 Jun; 34(6):404-15. PubMed ID: 4216878
    [No Abstract]   [Full Text] [Related]  

  • 2. [Follow-up of 131I-therapy of hyperthyroidism (author's transl)].
    Kinoshita F; Maekawa A; Kohda E; Kokamoto J; Shichiri Y
    Nihon Igaku Hoshasen Gakkai Zasshi; 1976; 36(2):128-42. PubMed ID: 1064000
    [No Abstract]   [Full Text] [Related]  

  • 3. [Results of 131I-therapy for hyperthyroidism (author's transl)].
    Tsuchigame T; Yoshii H; Hirota Y; Yasunaga T; Fujimura K; Kaneko T; Katayama K; Ichihara Y; Fukui K; Nakamura I
    Rinsho Hoshasen; 1979 Mar; 24(3):355-60. PubMed ID: 547075
    [No Abstract]   [Full Text] [Related]  

  • 4. [131I-therapy of hyperthyroidism--10 years' follow-up study].
    Tsuchigame T; Yasunaga T; Hirota Y; Yano K; Ueno S; Bussaka H; Takahashi M; Yoshii H; Fukui K; Nakamura I; Kaneko T
    Rinsho Hoshasen; 1983 May; 28(5):589-93. PubMed ID: 6887615
    [No Abstract]   [Full Text] [Related]  

  • 5. [Hyperthyroidism treated with I131. Late results (author's transl)].
    Atria P; Fuenzalida H; López JM; Michaud P; Arteaga E
    Rev Med Chil; 1981 Jul; 109(7):621-7. PubMed ID: 7330541
    [No Abstract]   [Full Text] [Related]  

  • 6. [Longsterm results of 131I treatment of hyperthyroidism--factors influencing the incidence of hypothyroidism (author's transl)].
    Hamada N; Ito K; Mimura T; Momotani N; Nishikawa Y; Ino E; Ban Y; Tsuchiya T
    Kaku Igaku; 1979 Dec; 16(8):1343-53. PubMed ID: 544871
    [No Abstract]   [Full Text] [Related]  

  • 7. [A case of atypical leukemia with monocytosis three years after 131I therapy of hyperthyroidism (author's transl)].
    Yonemitsu H; Kanazawa S; Kondo H; Yamaguchi K; Okuda K; Mikami K; Takasago M
    Rinsho Ketsueki; 1981 May; 22(5):673-7. PubMed ID: 6944518
    [No Abstract]   [Full Text] [Related]  

  • 8. An evaluation of the risk of developing hyperparathyroidism after 131I treatment for thyrotoxicosis.
    Fjälling M; Dackenberg A; Hedman I; Tisell LE
    Acta Chir Scand; 1983; 149(7):681-6. PubMed ID: 6650083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 131I therapy of hyperthyroidism: a five-year follow up.
    Khanna CM; Nath JK; Anand Y; Kochar BR
    J Indian Med Assoc; 1982 Dec; 79(11-12):153-6. PubMed ID: 7184967
    [No Abstract]   [Full Text] [Related]  

  • 10. [A case of myelogenous leukemia occurring 8 years following 131I therapy for hyperthyroidism (author's transl)].
    Sugiyama H; Shimada H; Senzaki S; Takahashi T; Horiuchi T; Hoshino T
    Rinsho Ketsueki; 1982 Mar; 23(3):356-64. PubMed ID: 6955535
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of hyperthyroidism using 131I: a retrospective study].
    Kamphuis JJ
    Ned Tijdschr Geneeskd; 1980 Jun; 124(26):1045-9. PubMed ID: 7402371
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment of thyrotoxicosis with radioactive iodine (131I). Evaluation of a method].
    Rønnov-Jessen AD; Grønbaek P
    Ugeskr Laeger; 1986 Jun; 148(25):1528-31. PubMed ID: 3529542
    [No Abstract]   [Full Text] [Related]  

  • 13. [Pursued objectives with the use of 131I for the treatment of hypothyroidism: analysis of 2 series receiving different doses].
    Aguayo J; Atria A; Pineda G
    Rev Med Chil; 1987 Apr; 115(4):308-13. PubMed ID: 3448739
    [No Abstract]   [Full Text] [Related]  

  • 14. Iodine-131 therapy of hyperthyroidism in pediatric patients.
    Clark JD; Gelfand MJ; Elgazzar AH
    J Nucl Med; 1995 Mar; 36(3):442-5. PubMed ID: 7884506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Results of 131iodine therapy of benign thyroid diseases (author's transl)].
    Pronath A; Buttermann G; Dirr W; Pabst HW
    MMW Munch Med Wochenschr; 1981 Dec; 123(51-52):1970-4. PubMed ID: 6798434
    [No Abstract]   [Full Text] [Related]  

  • 16. [Intravenous or oral 131I treatment of hyperthyroidism and thyroid cancer?].
    Müller KD; Grebe SF; Bock FL; Müller H; Fängewisch GL
    Nuklearmedizin; 1994 Jun; 33(3):87-92. PubMed ID: 8090631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The treatment of hyperthyroidism using iodine 131 (author's transl)].
    Baulieu JL; Leger FA; Savoie JC
    Chirurgie; 1978 Jun; 104(4):702-6. PubMed ID: 710230
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluation of the potential absorbed doses from patients based on whole-body 131I clearance in thyroid cancer therapy.
    Willegaignon J; Stabin MG; Guimarães MI; Malvestiti LF; Sapienza MT; Maroni M; Sordi GM
    Health Phys; 2006 Aug; 91(2):123-7. PubMed ID: 16832193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast cancer following iodine-131 therapy for hyperthyroidism.
    Hoffman DA; McConahey WM
    J Natl Cancer Inst; 1983 Jan; 70(1):63-7. PubMed ID: 6571923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Histological changes caused by treatment with radioactive isotopes (author's transl)].
    Hirose F
    Rinsho Byori; 1974 Aug; 22(Suppl):202-14. PubMed ID: 4473607
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.